Minoryx Therapeutics

The European Medicines Agency hit a 15-year high for positive drug recommendations in 2024, with 114 new medicines gaining a positive opinion for regulatory approval across the EU from its human medic

The European Medicines Agency has recommended granting pan-EU marketing approval to 14 new products, including Valneva ’s chikungunya vaccine Ixchiq and Pfizer / Spark Therapeutics ’ hemophilia B ge

The European Medicines Agency is this week due to decide whether to recommend in favor of pan-EU marketing authorization for fidanacogene elaparvovec, Pfizer / Spark Therapeutics ’ gene therapy for h

Two bird flu vaccines and four orphan drugs are among a host of new products on track for pan-EU approval following a thumbs up from the European Medicines Agency’s human medicines committee, the CHMP